Generic Name and Formulations:
Spironolactone, hydrochlorothiazide; 25mg/25mg, 50mg/50mg+; tabs; +scored.
Company:
Pfizer Inc.
Edema.
Not for initial therapy. Usual maintenance: 4 tabs daily in single or divided doses.
Not for initial therapy. Usual maintenance: 1.65–3.3mg spironolactone per kg daily.
K+-sparing + thiazide.
Hyperkalemia. Anuria. Renal impairment. Sulfonamide allergy. Severe hepatic impairment.
Hepatic cirrhosis. Hyponatremia. Surgery. Gout. Diabetes. SLE. Postsympathectomy. Monitor electrolytes. Pregnancy. Nursing mothers: not recommended.
Avoid K+ sparing diuretics, K+ supplements, K+ containing salt substitutes, lithium. Hyperkalemia more likely with ACE inhibitors, NSAIDs. Hypokalemia with amphotericin B, corticosteroids, ACTH. Potentiates alcohol, barbiturates, narcotics, skeletal muscle relaxants. May need to adjust insulin or oral hypoglycemic dosage. Antagonized by NSAIDs. Digitalis toxicity. May interfere with parathyroid tests.
Hyperkalemia, hyponatremia, gynecomastia, GI disturbances, drowsiness, headache, rash, confusion, drug fever, ataxia, impotence, hirsutism, voice deepening, menstrual changes, gastric ulcers, agranulocytosis. Electrolyte disorders (esp. hypokalemia), hyperglycemia, hyperuricemia, blood dyscrasias, photosensitivity, orthostatic hypotension, GI disturbances, adverse lipid values.
Tabs—100, 2500
Hypertension.
Usual maintenance: 50–100mg each of spironolactone and HCTZ daily in single or divided doses.
Not recommended.
Diuretic combination.
Hyperkalemia. Anuria. Renal impairment. Sulfonamide allergy. Severe hepatic impairment.
Hepatic cirrhosis. Hyponatremia. Surgery. Gout. Diabetes. SLE. Postsympathectomy. Monitor electrolytes. Pregnancy. Nursing mothers: not recommended.
Avoid K+ sparing diuretics, K+ supplements, K+ containing salt substitutes, lithium. Hyperkalemia more likely with ACE inhibitors, NSAIDs. Hypokalemia with amphotericin B, corticosteroids, ACTH. Potentiates alcohol, barbiturates, narcotics, skeletal muscle relaxants. May need to adjust insulin or oral hypoglycemic dosage. Antagonized by NSAIDs. Digitalis toxicity. May interfere with parathyroid tests.
Hyperkalemia, hyponatremia, gynecomastia, GI disturbances, drowsiness, headache, rash, confusion, drug fever, ataxia, impotence, hirsutism, voice deepening, menstrual changes, gastric ulcers, agranulocytosis. Electrolyte disorders (esp. hypokalemia), hyperglycemia, hyperuricemia, blood dyscrasias, photosensitivity, orthostatic hypotension, GI disturbances, adverse lipid values.
Tabs—100, 2500